Sanjay Kaul

11PUBLICATIONS
43CO-AUTHORS
Epidemiological modellingPacific Peoples social determinants of healthPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 13, 2022
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.

Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi

|Nov 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.

Javed Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi

|Dec 22, 2017
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.

William T Cefalu, Sanjay Kaul, Hertzel C Gerstein

|Jun 23, 2017
Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials.

Sanjay Kaul

Pageof 2

Frequent Collaborators

3 joint publications

Julio Rosenstock

3 joint publications

Matthew C Riddle

3 joint publications

George Bakris

3 joint publications

Robert Moses